ACCOUNTS - Final Accounts

Registered number: 13739686

NEURITA LTD

UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 NOVEMBER 2024

NEURITA LTD

REGISTERED NUMBER: 13739686

BALANCE SHEET

AS AT 30 NOVEMBER 2024

		2024		2023
Note		£		£

FIXED ASSETS
Intangible assets	4		1,196		1,619
CURRENT ASSETS
Stocks		77,176		82,253
Debtors: amounts falling due within one year	5	12,168		14,680
Cash at bank and in hand		70,081		47,512
		159,425		144,445
Creditors: amounts falling due within one year	6	(90,279)		(81,995)
NET CURRENT ASSETS			69,146		62,450
TOTAL ASSETS LESS CURRENT LIABILITIES			70,342		64,069

NET ASSETS			70,342		64,069

CAPITAL AND RESERVES
Called up share capital	7	23,311	22,707
Share premium account		313,667	229,536
Profit and loss account		(266,636)	(188,174)
		70,342	64,069

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

Page 1

NEURITA LTD

REGISTERED NUMBER: 13739686

BALANCE SHEET (CONTINUED)

AS AT 30 NOVEMBER 2024

The financial statements were approved and authorised for issue by the board and were signed on its behalf by:

L Smith

Director

Date: 1 September 2025

The notes on pages 3 to 6 form part of these financial statements.

Page 2

NEURITA LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 NOVEMBER 2024

1.	GENERAL INFORMATION

Neurita Ltd is a private company limited by shares and incorporated in England and Wales. Its registered office is 2 South Frith, London Road, Tunbridge Wells, TN4 0UQ.
The figures in the accounts are rounded to the nearest pound.

2.ACCOUNTING POLICIES

2.1

BASIS OF PREPARATION OF FINANCIAL STATEMENTS

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

2.2

FOREIGN CURRENCY TRANSLATION

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Profit and Loss Account within 'finance income or costs'. All other foreign exchange gains and losses are presented in profit or loss within 'other operating income'.

2.3

TURNOVER

Turnover is recognised to the extent that it is probable that the economic benefits will flow to the Company and the turnover can be reliably measured. Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

2.4

INTEREST INCOME

Interest income is recognised in profit or loss using the effective interest method.

Page 3

NEURITA LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 NOVEMBER 2024

2.ACCOUNTING POLICIES (CONTINUED)

2.5

BORROWING COSTS

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

2.6

INTANGIBLE ASSETS

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

The estimated useful lives range as follows:

Trademarks

years

2.7

STOCKS

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

2.8

DEBTORS

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

2.9

CREDITORS

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

2.10

TAXATION

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Page 4

NEURITA LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 NOVEMBER 2024

3.	EMPLOYEES
	The average monthly number of employees, including directors, during the year was 2 (2023 - 2).

4.	INTANGIBLE ASSETS

		Trademarks
		£
	COST
	At 1 December 2023	2,111
	At 30 November 2024	2,111
	AMORTISATION
	At 1 December 2023	492
	Charge for the year on owned assets	423
	At 30 November 2024	915
	NET BOOK VALUE
	At 30 November 2024	1,196
	At 30 November 2023	1,619

DEBTORS

					2024	2023
					£	£


Trade debtors	5,576	705
Other debtors	6,206	10,175
Prepayments and accrued income	386	3,800
	12,168	14,680

Page 5

NEURITA LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 NOVEMBER 2024

6.	CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
		2024	2023
		£	£

Other loans	67,766	69,176
Trade creditors	13,884	10,069
Other creditors	2,475	-
Accruals and deferred income	6,154	2,750
	90,279	81,995

7.	SHARE CAPITAL
		2024	2023
		£	£

ALLOTTED, CALLED UP AND FULLY PAID

2,331,091 (2023 - 2,270,672) Ordinary shares of £0.01 each	23,311	22,707

On 19 March 2024, 21,052 £0.01 Ordinary shares were issued for a total consideration of £20,000.
On 14 August 2024, 24,575 £0.01 Ordinary shares were issued for a total consideration of £41,532.
On 7 November 2024, 11,834 £0.01 Ordinary shares were issued for a total consideration of £20,000.
On 20 November 2024, 2,958 £0.01 Ordinary shares were issued for a total consideration of £5.000.

Page 6